Gerium Medical
Noninvasive Bilirubin Measurement Device
Company Overview
Snapshot
Founded in January 2011 by Moshe Gerber, Gerium Medical operated with 1–10 employees. The company raised $550,000 across 3 funding rounds from 3 investors. A significant milestone was its acquisition by Mennen Medical group in June 2015.
Business overview
Gerium Medical developed BiliCare, a noninvasive bilirubin meter for newborns. This technology utilizes spectroscopy to measure transcutaneous bilirubin levels by analyzing light absorption through the newborn's ear. The device, which is CE-marked, is designed for neonatal jaundice diagnoses, serving the health tech and life sciences sector, particularly hospitals and healthcare providers focused on infant care.
Strategic signal
In October 2015, news highlighted the BiliCare device's sensor technology as key to noninvasive medical measurement. This underscores the company's contribution to advancing diagnostic methods in neonatal care, demonstrating the market's recognition of its innovative approach even after its acquisition.
Log in to access full profile ›Company Intelligence Q&A
- When was Gerium Medical founded?
- Gerium Medical was founded in January 2011.
- What is Gerium Medical's primary product?
- Gerium Medical's primary product is BiliCare, a noninvasive bilirubin meter for newborns, which uses spectroscopy for neonatal jaundice diagnoses.
- When was Gerium Medical acquired?
- Gerium Medical was acquired by Mennen Medical group in June 2015.
- Which investors participated in Gerium Medical's Seed round?
- In April 2011, Gerium Medical secured Seed funding from the Office of the Chief Scientist and Naiot Venture Accelerator.
- What was the total capital raised by Gerium Medical?
- Gerium Medical raised a total of $550,000 across its funding rounds.